Big Data on Financial Report of Pharmaceutical Preparations

Pharmaceutical Preparations Annual report

Alnylam (NASDAQ: ALNY)

ALNYLAM PHARMACEUTICALS, INC.
Industry: Pharmaceutical

Period	Opening price	Closing price	Growth rate	Report date
2025Q3	450.000	322.280	-28.38%	2025-10-30

$ALNY Quarterly report

$ALNY Annual report

$ALNY Assets

BridgeBio (NASDAQ: BBIO)

BridgeBio Pharma, Inc.
Industry:

$BBIO Annual report

$BBIO Assets

BIOMARIN (NASDAQ: BMRN)

BioMarin Pharmaceutical Inc.
BIOMARIN PHARMACEUTICAL INC
Industry: Biotechnology

$BMRN Annual report

BIOMARIN (NASDAQ: INSM)

INSMED INCORPORATED
INSMED Inc
Industry:

$INSM Quarterly report

$INSM Annual report

$INSM Assets

ROYALTY PHARMA (NASDAQ: RPRX)

Royalty Pharma plc
United Kingdom
Industry:

$RPRX Annual report

Summit (NASDAQ: SMMT)

Summit Therapeutics Inc.
Industry:

$SMMT Annual report

SAREPTA THERAPEUTICS (NASDAQ: SRPT)

SAREPTA THERAPEUTICS, INC.
Sarepta Therapeutics, Inc.
Industry:

$SRPT Annual report

teva (NYSE: TEVA)

TEVA PHARMACEUTICAL INDUSTRIES LIMITED (also known as Teva Pharmaceuticals)
TEVA PHARMACEUTICAL INDUSTRIES LTD
Israel
Industry: Pharmaceutical

  Some rounding errors in the BS, IS, SOCF have been corrected.

$TEVA Annual report

United Therapeutics (NASDAQ: UTHR)

United Therapeutics Corporation
UNITED THERAPEUTICS Corp
Industry: Biotechnology

$UTHR Quarterly report

$UTHR Annual report

$UTHR Assets

VIATRIS (NASDAQ: VTRS)

VIATRIS INC.
Viatris Inc
Industry: Pharmaceuticals, Healthcare

$VTRS Annual report

$VTRS Assets